Activities of wildtype and mutant p53 in suppression of homologous recombination as measured by a retroviral vector system

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 522, Issue 1-2, 2003, Pages 69-83

  Lu, Xiongbin ^a   Lozano, Guillermina ^b   Donehower, Lawrence A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Double strand DNA break repair; Homologous recombination; Ionizing radiation; p53; Retroviral vector

Indexed keywords

MUTANT PROTEIN; NEOMYCIN; PROTEIN P53; RETROVIRUS VECTOR;

ARTICLE; CANCER CELL; CELL MUTANT; CELL TYPE; CONTROLLED STUDY; FIBROBLAST; FUSION GENE; GENETIC TRANSFECTION; HOMOLOGOUS RECOMBINATION; IONIZING RADIATION; MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; TANDEM REPEAT; WILD TYPE;

DNA REPAIR; GENETIC MARKERS; GENETIC VECTORS; HUMANS; MUTATION, MISSENSE; RADIATION, IONIZING; RECOMBINATION, GENETIC; RETROVIRIDAE; TUMOR SUPPRESSOR PROTEIN P53;

RODENTIA;

EID: 0037469359     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(02)00261-0     Document Type: Article

References (36)

1. Lengauer C., Kinzler K.W., Vogelstein B. Genetic instabilities in human cancers. Nature. 396:1998;643-649.
2. Hoeijmakers J.H. Genome maintenance mechanisms for preventing cancer. Nature. 411:2001;366-374.
3. Thompson L.H., Schild D. Homologous recombinational repair of DNA ensures mammalian chromosome stability. Mutat. Res. 477:2001;131-153.
4. Bishop A.J., Schiestl R.H. Homologous recombination as a mechanism of carcinogenesis. Biochim. Biophys. Acta. 1471:2001;M109-M121.
5. van Gent D.C., Hoeijmakers J.H., Kanaar R. Chromosomal stability and the DNA double-stranded break connection. Nat. Rev. Genet. 2:2001;196-206.
6. Vogelstein B., Lane D., Levine A.J. Surfing the p53 network. Nature. 408:2000;307-310.
7. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell. 88:1997;323-331.
8. Lozano G., Elledge S.J. p53 sends nucleotides to repair DNA. Nature. 404:2000;24-25.
9. Malkin D., Li F.P., Strong L.C., Fraumeni J.F. Jr., Nelson C.E., Kim D.H., Kassel J., Gryka M.A., Bischoff F.Z., Tainsky M.A., Friend S. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science. 250:1990;1233-1238.
10. Donehower L.A., Harvey M., Slagle B.L., McArthur M.J., Montgomery C.A. Jr., Butel J.S., Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature. 356:1992;215-221.
11. Bischoff F.Z., Yim S.O., Pathak S., Grant G., Siciliano M.J., Giovanella B.C., Strong L.C., Tainsky M.A. Spontaneous abnormalities in normal fibroblasts from patients with Li-Fraumeni cancer syndrome: aneuploidy and immortalization. Cancer Res. 50:1990;7979-7984.
12. Harvey M., Sands A.T., Weiss R.S., Hegi M.E., Wiseman R.W., Pantazis P., Giovanella B.C., Tainsky M.A., Bradley A., Donehower L.A. In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene. 8:1993;2457-2467.
13. Livingstone A.R., White A., Sprouse J., Livanos E., Jacks T., Tlsty T.D. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell. 70:1992;923-935.
14. Yin Y., Tainsky M.A., Bischoff F.Z., Strong L.C., Wahl G.M. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell. 70:1992;937-948.
15. Sturzbecher H.W., Donzelmann B., Henning W., Knippschild U., Buchhop S. p53 is linked directly to homologous recombination processes via RAD51/RecA protein interaction. EMBO J. 15:1996;1992-2002.
16. Mekeel K.L., Tang W., Kachnic L.A., Luo C.M., DeFrank J.S., Powell S.N. Inactivation of p53 results in high rates of homologous recombination. Oncogene. 14:1997;1847-1857.
17. Willers H., McCarthy E.E., Wu B., Wunsch H., Tang W., Taghian D.G., Xia F., Powell S.N. Dissociation of p53-mediated suppression of homologous recombination from G1/S cell cycle checkpoint control. Oncogene. 19:2000;632-639.
18. Gebow D., Miselis N., Liber H.L. Homologous and non-homologous recombination resulting in deletion: effects of p53 status, microhomology, and repetitive DNA length and orientation. Mol. Cell. Biol. 20:2000;4028-4035.
19. Bertrand P., Rouillard D., Boulet A., Levalois C., Soussi T., Lopez B.S. Increase of spontaneous intrachromosomal homologous recombination in mammalian cells expressing a mutant p53 protein. Oncogene. 14:1997;1117-1122.
20. Saintigny Y., Rouillard D., Chaput B., Soussi T., Lopez B.S. Mutant p53 proteins stimulate spontaneous and radiation-induced intrachromosomal homologous recombination independently of the alteration of the transactivation activity and of the G1 checkpoint. Oncogene. 18:1999;3553-3563.
21. Saintigny Y., Lopez B.S. Homologous recombination induced by replication inhibition, is stimulated by expression of mutant p53. Oncogene. 21:2002;488-492.
22. Dudenhoffer C., Kurth M., Janus F., Deppert W., Wiesmuller L. Dissociation of the recombination control and the sequence-specific transactivation function of p53. Oncogene. 18:1999;5773-5784.
23. Subramanian D., Griffith J.D. Interactions between p53, hMSH2-hMSH6 and HMG I(Y) on Holliday junctions and bulged bases. Nucl. Acids Res. 30:2002;2427-2434.
24. Q. Yang, R. Zhang, X.W. Wang, E.A. Spillare, S.P. Linke, D. Subramanian, J.D. Griffith, J.L. Li, I.D. Hickson, L.A. Loeb, S.J. Mazur, E. Appella, R.M. Brosh Jr, P. Karmakar, V.A. Bohr, C.C. Harris, The processing of Holliday junctions by BLM and WRN helicases is regulated by p53. J Biol Chem. (2002) Jun 21 [epub ahead of print].
25. Buchhop S., Gibson M.K., Wang X.W., Wagner P., Sturzbecher H.W., Harris C.C. Interaction of p53 with the human Rad51 protein. Nucl. Acids. Res. 25:1997;3868-3874.
26. Akyuz N., Boehden G.S., Susse S., Rimek A., Preuss U., Scheidtmann K.H., Wiesmuller L. DNA substrate dependence of p53-mediated regulation of double-strand break repair. Mol. Cell. Biol. 22:2002;6306-6317.
27. Liang L., Shao C., Deng L., Mendonca M.S., Stambrook P.J., Tischfield J.A. Radiation-induced genetic instability in vivo depends on p53 status. Mutat. Res. 502:2002;69-80.
28. Blander G., Kipnis J., Leal J.F., Yu C.E., Schellenberg G.D., Oren M. Physical and functional interaction between p53 and the Werner's syndrome protein. J. Biol. Chem. 274:1999;29463-29469.
29. Spillare E.A., Robles A.I., Wang X.W., Shen J.C., Yu C.E., Schellenberg G.D., Harris C.C. p53-mediated apoptosis is attenuated in Werner syndrome cells. Gen. Dev. 13:1999;1355-1360.
30. Wang X.W., Tseng A., Ellis N.A., Spillare E.A., Linke S.P., Robles A.I., Seker H., Yang Q., Hu P., Beresten S., Bemmels N.A., Garfield S., Harris C.C. Functional interaction of p53 and BLM DNA helicase in apoptosis. J. Biol. Chem. 276:2001;32948-32955.
31. Kumar M., Keller B., Makalou N., Sutton R.E. Systematic determination of the packaging limit of lentiviral vectors. Hum. Gene Ther. 12:2001;1893-1905.
32. Harvey M., Sands A.T., Weiss R.S., Hegi M.E., Wiseman R.W., Pantazis P., Giovanella B.C., Tainsky B.C., Bradley A., Donehower L.A. In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene. 8:1993;2457-2467.
33. Masuda H., Miller C., Koeffler H.P., Battifora H., Cline M.J. Rearrangement of the p53 gene in human osteogenic sarcomas. Proc. Natl. Acad. Sci. U.S.A. 84:1987;7716-7719.
34. Romano J.W., Ehrhart J.C., Duthu A., Kim C.M., Appella E., May P. Identification and characterization of a p53 gene mutation in a human osteosarcoma cell line. Oncogene. 4:1989;1483-1488.
35. Diller L., Kassel J., Nelson C.E., Gryka M.A., Litwak G., Gebhardt M., Bressac B., Ozturk M., Baker S.J., Vogelstein B., Friend S.H. p53 functions as a cell cycle control protein in osteosarcomas. Mol. Cell. Biol. 10:1990;5772-5781.
36. Martinez J., Georgoff I., Martinez J., Levine A.J. Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. Gen. Dev. 5:1991;151-159.